Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > Friday began on a high note for marijuana stocks, as investm
View:
Post by bligicka on May 09, 2021 8:46am

Friday began on a high note for marijuana stocks, as investm

Friday began on a high note formarijuana stocks, as investment bank Jefferies announced it was turning around its opinion ofTilray(NASDAQ:TLRY)stock 180 degrees, upgrading the shares from underperform all the way to buy. Tilray stock responded as you'd expect, surging 17% in morning trading, but other marijuana stocks are responding positively as well. As of 11 a.m. EDT,Canopy Growth(NASDAQ:CGC)stock is up a strong 6%,HEXO(NYSE:HEXO)is even better at 7%, andAurora Cannabis(NYSE:ACB)is best of all with a 7.5% gain. But why is good news for Tilray good news for these rival cannabis companies, too?
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities